Plasma 3, 4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4- hydroxyphenylglycol (MHPG) are insensitive indicators of α2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers
- 31 December 1991
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 49 (1), 75-84
- https://doi.org/10.1016/0024-3205(91)90581-u
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2‐adrenoceptor antagonist‐a randomized, double‐blind cross‐over study in healthy male volunteers.British Journal of Clinical Pharmacology, 1990
- Effects of dexmedetomidine, a selective α2-adrenoceptor agonist, on hemodynamic control mechanismsClinical Pharmacology & Therapeutics, 1989
- Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.Journal of Clinical Investigation, 1988
- Noradrenergic Function in SchizophreniaArchives of General Psychiatry, 1987
- Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolismLife Sciences, 1985
- Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjectsAmerican Journal of Psychiatry, 1984
- Yohimbine induced anxiety and increased noradrenergic function in humans: Effects of diazepam and clonidineLife Sciences, 1983
- Modulation of the concentration of noradrenaline at the neuro‐effector junction in human saphenous veinBritish Journal of Pharmacology, 1983
- Assessment of α2 adrenergic autoreceptor function in humans: Effects of oral yohimbineLife Sciences, 1982
- Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) in man: Preliminary reportLife Sciences, 1980